Brind.

Gilead Sciences supports Native Son Awards featuring Terrell Carter, with a fellowship debut scheduled in New York.

1 report, 1 independent Updated Jun 18

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Terrell CarterGilead Sciences

Keep exploring

The entities involved

Gilead Sciences
American company
- FDA approved lenacapavir (Yeztugo) on August 18, 2025, solidifying the HIV portfolio for Gilead Sciences.Mon 18:04
- Dean Hakanson led U.S. Medical Affairs for the remdesivir launch and served in senior leadership positions at major pharmaceutical companies.Mon 17:32

Coverage

Newest first; wire copies grouped

Jun 18blackenterprise.com